Treatment patterns of FIGO Stage IB2 cervical cancer: A single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy

Gynecologic Oncology

Volumn 111, Issue 2, 2008, Pages 265-270

  Zivanovic, Oliver ^a   Alektiar, Kaled M ^a   Sonoda, Yukio ^a   Zhou, Qin ^a   Iasonos, Alexia ^a   Tew, William P ^a   Diaz, John P ^a   Chi, Dennis S ^a   Barakat, Richard R ^a   Abu Rustum, Nadeem R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemoradiation therapy; FIGO stage IB2 cervical carcinoma; Radical hysterectomy

Indexed keywords

BLEOMYCIN; CISPLATIN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOOD TOXICITY; BRACHYTHERAPY; BRAIN HEMORRHAGE; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; COLITIS; CONTROLLED STUDY; CYSTITIS; DEEP VEIN THROMBOSIS; DIARRHEA; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FECES INCONTINENCE; FEMALE; FEVER; GASTROINTESTINAL TOXICITY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INTERMETHOD COMPARISON; LEG EDEMA; LUNG EMBOLISM; LYMPHOCELE; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUROGENIC BLADDER; NEUROTOXICITY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROCTITIS; RADICAL HYSTERECTOMY; RECTUM HEMORRHAGE; SKIN TOXICITY; STRESS INCONTINENCE; TREATMENT OUTCOME; UROGENITAL TRACT DISEASE; UTERINE CERVIX CANCER; VAGINA DISEASE; VAGINA STENOSIS; WASTING SYNDROME; WOUND INFECTION;

ADULT; AGED; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 55649119590     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.07.050     Document Type: Article

References (26)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94 (2001) 153-156
2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., and Thun M.J. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
3. Delgado G., Bundy B.N., Fowler Jr. W.C., Stehman F.B., Sevin B., Creasman W.T., et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol 35 (1989) 314-320
4. Perez C.A., Grigsby P.W., Nene S.M., Camel H.M., Galakatos A., Kao M.S., et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 69 (1992) 2796-2806
5. Landoni F., Maneo A., Colombo A., Placa F., Milani R., Perego P., et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350 (1997) 535-540
6. Homesley H.D., Raben M., Blake D.D., Ferree C.R., Bullock M.S., Linton E.B., et al. Relationship of lesion size to survival in patients with stage IB squamous cell carcinoma of the cervix uteri treated by radiation therapy. Surg Gynecol Obstet 150 (1980) 529-531
7. Eifel P.J., Morris M., Wharton J.T., and Oswald M.J. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 29 (1994) 9-16
8. Piver M.S., and Chung W.S. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol 46 (1975) 507-510
9. Rettenmaier M.A., Casanova D.M., Micha J.P., Moran M.F., Ramsanghani N.S., Syed N.A., et al. Radical hysterectomy and tailored postoperative radiation therapy in the management of bulky stage 1B cervical cancer. Cancer 63 (1989) 2220-2223
10. Keys H.M., Bundy B.N., Stehman F.B., Okagaki T., Gallup D.G., Burnett A.F., Gynecologic Oncology Group, et al. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. Gynecol Oncol 89 (2003) 343-353
11. Ryu H.S., Kang S.B., Kim K.T., Chang K.H., Kim J.W., and Kim J.H. Efficacy of different types of treatment in FIGO stage IB2 cervical cancer in Korea: results of a multicenter retrospective Korean study (KGOG-1005). Int J Gynecol Cancer 17 (2007) 132-136
12. Chang T.C., Lai C.H., Hong J.H., Hsueh S., Huang K.G., Chou H.H., et al. Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer. J Clin Oncol 18 (2000) 1740-1747
13. Micha J.P., Goldstein B.H., Rettenmaier M.A., Brown III J.V., John C.R., and Markman M. Surgery alone or surgery with a combination radiation or chemoradiation for management of patients with bulky-stage IB2 cervical carcinoma. Int J Gynecol Cancer 16 (2006) 1147-1151
14. Morley G.W., and Seski J.C. Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix (exclusive of microinvasion). Am J Obstet Gynecol 126 (1976) 785-798
15. Hopkins M.P., and Morley G.W. Radical hysterectomy versus radiation therapy for stage IB squamous cell cancer of the cervix. Cancer 68 (1991) 272-277
16. Shingleton H.M., Jones W.B., Russell A., Fremgen A., Chmiel J.S., Ocwieja K., et al. Hysterectomy in invasive cervical cancer: a national patterns of care study of the American College of Surgeons. J Am Coll Surg 183 (1996) 393-400
17. Russell A.H., Shingleton H.M., Jones W.B., Stewart A.K., Fremgen A., Winchester D.P., et al. Trends in the use of radiation and chemotherapy in the initial management of patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 40 (1998) 605-613
18. Rocconi R.P., Chiang S., Richter H.E., and Straughn Jr. J.M. Management strategies for abnormal early pregnancy: a cost-effectiveness analysis. J Reprod Med 50 (2005) 486-490
19. Jewell E.L., Kulasingam S., Myers E.R., Alvarez Secord A., and Havrilesky L.J. Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis. Gynecol Oncol 107 (2007) 532-540
20. Piver M.S., Rutledge F., and Smith J.P. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 44 (1974) 265-272
21. Curtin J.P., Hoskins W.J., Venkatraman E.S., Almadrones L., Podratz K.C., Long H., et al. Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase III trial. Gynecol Oncol 61 (1996) 3-10
22. Fuller Jr. A.F., Elliott N., Kosloff C., Hoskins W.J., and Lewis Jr. J.L. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol Oncol 33 (1989) 34-39
23. Peters III W.A., Liu P.Y., Barrett II R.J., Stock R.J., Monk B.J., Berek J.S., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613
24. Sedlis A., Bundy B.N., Rotman M.Z., Lentz S.S., Muderspach L.I., and Zaino R.J. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Gynecol Oncol 73 (1999) 177-183
25. Kjorstad K.E., Martimbeau P.W., and Iversen T. Stage IB carcinoma of the cervix, the Norwegian Radium Hospital: results and complications. III. Urinary and gastrointestinal complications. Gynecol Oncol 15 (1983) 42-47
26. Keys H.M., Bundy B.N., Stehman F.B., Muderspach L.I., Chafe W.E., Suggs III C.L., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340 (1999) 1154-1161 Erratum in: N Engl J Med 1999;341:708